Microcap Ledger Petmed Express Inc $PETS
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Global Select Market
- Sector
- Retail-Drug Stores and Proprietary Stores
- Headquarters
- Delray Beach, FL
- Fiscal year end
- March 31
- Shares outstanding
- 21,678,914 [10-Q 2026-08-13]
What the company doesAI summary of filing
PetMed Express, Inc., operating as PetMeds and parent company of PetCareRx, is a direct-to-consumer online pet pharmacy that sells prescription medications, generic medications, compounded medications, over-the-counter health products, and pet food and supplies to pet owners in all 50 U.S. states. The company generates revenue by fulfilling orders placed through its websites (Petmeds.com and PetCareRx.com), mobile applications, and customer contact centers, with customers obtaining veterinary prescription approval through the company's verification process before shipment. The company operates two licensed pharmacy facilities in Florida and New York and serves chronic and acute pet health conditions for dogs, cats, and horses. PetMed Express is revenue-generating, having fulfilled orders for approximately twenty million customers over its 30-year history and attracting 266,000 new customers in fiscal 2026. [10-K 2026-06-02]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 3 months to Jun 2026 | $41.02M | −$6.14M | −$7.69M | $13.08M | [10-Q 2026-08-13] |
| FY ended Mar 2026 | $179.02M | −$57.29M | −$28.39M | $21.41M | [10-K 2026-06-02] |
| FY ended Mar 2025 | $226.97M | −$6.27M | $4.72M | $54.72M | [10-K 2026-06-02] |
- Quarterly cash burn
- −$7.69M
- Cash runway Estimate
- ~5.1 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-08-07 | 20,600,652 | [10-Q 2024-08-07] |
| 2024-11-07 | 20,663,218 | [10-Q 2024-11-07] |
| 2025-02-10 | 20,656,457 | [10-Q 2025-02-10] |
| 2025-09-30 | 21,015,559 | [10-K 2025-10-14] |
| 2025-12-05 | 21,369,521 | [10-Q 2025-12-19] |
| 2026-01-30 | 21,400,495 | [10-Q 2026-02-05] |
| 2026-05-22 | 21,365,782 | [10-K 2026-06-02] |
| 2026-08-07 | 21,678,914 | [10-Q 2026-08-13] |
Listing status
Current status: 3 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2025-11-13. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2025-11-13 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-11-13] |
| 2025-08-25 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-08-25] |
| 2025-07-03 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-07-03] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-09-28 | Willard Jeffrey Allen | grant | 250,000 | — | [4 2026-09-29] |
| 2026-09-17 | Elkeles Tamar | grant | 49,923 | — | [4 2026-09-21] |
| 2026-08-11 | Campbell Leslie C.G. | grant | 60,000 | — | [4 2026-08-13] |
| 2026-08-11 | Lacamp James | grant | 55,555 | — | [4 2026-08-12] |
| 2026-08-11 | Batushansky Peter | grant | 55,555 | — | [4 2026-08-12] |
| 2026-08-11 | Mennen Justin L. | grant | 55,555 | — | [4 2026-08-12] |
| 2026-06-26 | Krulik Douglas | grant | 32,500 | — | [4 2026-06-26] |
| 2026-06-08 | Nina Capital Holdings Inc. | buy | 25,000 | $1.75 | [4 2026-06-09] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-09-28 | 8-K | Director or officer change |
| 2026-09-21 | 8-K | Director or officer change; Regulation FD disclosure |
| 2026-09-17 | 8-K | Director or officer change; Regulation FD disclosure |
| 2026-08-13 | 10-Q | Quarterly report |
| 2026-08-13 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-08-13 | 8-K | Results of operations |
| 2026-08-12 | 8-K | Director or officer change; Shareholder vote results |
| 2026-07-23 | 8-K | Material agreement entered; Regulation FD disclosure |
| 2026-06-29 | 13D/A | Beneficial ownership report (5%+ holder) |
| 2026-06-26 | 8-K | Director or officer change |
| 2026-06-25 | DEF 14A | Proxy statement |
| 2026-06-02 | 10-K | Annual report |
Alerts for $PETS
Email me when Petmed Express Inc files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.